2008
DOI: 10.1590/s0034-70942008000300010 View full text |Buy / Rent full text
|
|

Abstract: Pure delta-9-tetrahydrocannabinol (Delta9-THC) and its analogues have clinical applicability, being beneficial in selected individuals. The development of pure synthetic substances, in an attempt to attenuate undesirable psychoactive effects, indicates that perspectives for its use in the future are favorable. More detailed studies should be undertaken. Ample debates will be necessary to create standards for its formulation and clinical availability, since it is a substance that generates prejudice, due to its… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
4
0
27

Publication Types

Select...

Relationship

0
0

Authors

Journals